Displaying drugs 151 - 175 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Erenumab | C6472H9964N1728O2018S50 |  | A calcitonin-gene related peptide antagonist used to prevent migraines. | Calcitonin Gene-Related Peptide (CGRP) Antagonists / Calcitonin Gene-Related Peptide Receptor Antagonists |
| Erythropoietin | 18396.1 C815H1317N233O241S5 |  | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. | Colony-Stimulating Factors / Erythropoiesis-Stimulating Agents / Erythropoietin, genetics / Hematinics |
| Etanercept | 51234.9 C2224H3475N621O698S36 |  | A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Evinacumab | 146000.0 | | A monoclonal antibody targeted against angiopoetin-like protein 3 (ANGPTL3) used as an adjunct with other lipid-lowering therapies for the treatment of homozygous familiar hypercholesterolemia. | Angiopoietin-like 3 Inhibitor |
| Evolocumab | 141800.0 C6242H9648N1668O1996S56 |  | A PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures. | Anticholesteremic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor |
| Exenatide | 4186.6 C184H282N50O60S |  | A GLP-1 agonist used in the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Factor IX Complex (Human) | Not Available | | A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Factor IX |
| Factor XIII (human) | Not Available | | A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency. | Blood Coagulation Factors / Enzyme Precursors / Factor XIIIa, antagonists & inhibitors / Transglutaminases |
| Fanolesomab | Not Annotated | | An anti-SSEA-1 monoclonal antibody used for imaging of the appendix and to diagnose appendicitis. | Lewis X Antigen |
| Faricimab | 149000.0 C6506H9968N1724O1026S45 | | An IgG1-derived bispecific antibody against VEGF-A and Ang-2 for the treatment of age-related macular degeneration and diabetic macular edema. | Angiogenesis Inhibitors / Antineovascularisation Agents |
| Fecal microbiota | Not Available | | A bacterial suspension manufactured from human fecal matter used to prevent the recurrence of Clostridioides difficile infection. | Miscellaneous Therapeutic Agents |
| Fibrinogen human | Not Available | | A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. | Fibrinogen |
| Filgrastim | 18800.0 C845H1339N223O243S9 |  | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. | Colony-Stimulating Factors |
| Follitropin | 22672.9 C975H1513N267O304S26 |  | A form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism. | Follicle Stimulating Hormone / Gonadotropins / Gonadotropins, Pituitary / Hormones / Thyroid Products |
| Fremanezumab | 148000.0 |  | A humanized monoclonal antibody directed against human calcitonin-gene related peptide to prevent migraines. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
| Galcanezumab | 147000.0 | | A calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches. | Calcitonin Gene-Related Peptide (CGRP) Antagonists / Calcitonin Gene-Related Peptide Receptor Antagonists |
| Galsulfase | 56012.6 C2534H3851N691O719S16 |  | A recombinant human enzyme used as replacement enzyme therapy for the treatment of of adults and children with Mucopolysaccharidosis VI, a rare genetic disorder caused by a deficiency of a lysosomal enzyme. | Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Gastric intrinsic factor | Not Available | | Intrinsic factor is not currently available in any FDA or Health Canada approved products. However, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic... | Intrinsic Factor / Mucoproteins |
| Gemtuzumab ozogamicin | 151500.0 |  | A monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia. | Antibodies, Monoclonal |
| Glatiramer | 7000.0 (C5H9NO4•C3H7NO2•C6H14N2O2•C9H11NO3)x•xC2H4O2 | | An immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS). | Adjuvants, Immunologic |
| Glofitamab | 194000.0 | | A bispecific monoclonal antibody directed against CD20 and CD3 which is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Bispecific Monoclonal Antibodies / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Glucagon | 3767.1 C165H249N49O51S1 |  | A form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures. | Glycogenolytic Hormones |
| Glucarpidase | 83000.0 C3670H5926N10114O1140S12 |  | A carboxypeptidase enzyme used to reduce plasma concentrations of methotrexate in patients with impaired renal function. | Detoxifying Agents for Antineoplastic Treatment |
| Golimumab | 146943.1937 C6530H10068N1752O2026S44 |  | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Guselkumab | 143.6 C6402H9864N1676O1994S42 | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
Displaying drugs 151 - 175 of 406 in total